DGMT CTP In Vivo MN kits
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Points of contact
-
- NCTR Acquisition Liaison nctracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a new requirement for DGMT CTP In Vivo MN kits, specifically Comet assay supplies including the Manju C24020 model and related materials. The solicitation is expected to be released on December 1, 2025, with an estimated award date of January 1, 2026. This procurement falls under the Biological Product Manufacturing category (NAICS 325414) and does not utilize a set-aside restriction.
The estimated contract award value ranges from $25,000 to $250,000. No specific quantity of units or extended service timeline details are provided in the forecast documentation. Interested contractors should direct inquiries to the FDA's Acquisition Liaison at nctracquisitions@fda.hhs.gov for additional information regarding this opportunity and its specific requirements.
Forecast text
DGMT CTP Comet assay supplies Manju C24020 & Carol
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast